Douglas Veale Selected Research

Douglas Veale Research Topics

10	Rheumatoid Arthritis 01/2023 - 03/2002
4	Psoriatic Arthritis 03/2023 - 06/2007
4	Arthritis (Polyarthritis) 01/2022 - 01/2010
2	Hyperplasia 01/2023 - 07/2012
2	Neoplasms (Cancer) 02/2021 - 01/2015
2	Fatigue 01/2017 - 05/2010
2	Joint Diseases (Joint Disease) 10/2013 - 10/2012
2	Systemic Scleroderma (Systemic Sclerosis) 01/2007 - 11/2002
1	Wounds and Injuries (Trauma) 01/2023
1	Arthralgia (Joint Pain) 01/2022
1	Ankylosing Spondylitis 01/2021
1	Inflammation (Inflammations) 10/2013
1	Necrotizing Fasciitis 08/2013
1	Miliary Tuberculosis 03/2012
1	Pain (Aches) 05/2010
1	Skin Diseases (Skin Disease) 05/2008
1	Psoriasis (Pustulosis Palmaris et Plantaris) 06/2007
1	Diffuse Scleroderma (Progressive Systemic Sclerosis) 01/2007
1	Interstitial Lung Diseases (Interstitial Lung Disease) 11/2002
1	Pneumonia (Pneumonitis) 11/2002
1	Synovitis 03/2002

4	Methotrexate (Mexate)FDA LinkGeneric 02/2021 - 06/2007
3	ametantrone (HAQ)IBA 05/2010 - 05/2008
2	Semaphorins (Semaphorin)IBA 01/2023 - 01/2022
2	Matrix Metalloproteinases (MMPs)IBA 01/2022 - 07/2012
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2002 - 03/2002
1	fluorexon (calcein)IBA 01/2023
1	EnzymesIBA 01/2022
1	ImmunosorbentsIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	Immune Checkpoint InhibitorsIBA 02/2021
1	tofacitinibIBA 02/2021
1	Prednisolone (Predate)FDA LinkGeneric 02/2021
1	Janus KinasesIBA 02/2021
1	C-Reactive ProteinIBA 01/2021
1	Etanercept (Enbrel)FDA Link 01/2016
1	Thrombospondin 1IBA 10/2013
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2013
1	Phosphoprotein Phosphatases (Phosphatases, Protein)IBA 01/2013
1	Tyrosine (L-Tyrosine)FDA Link 01/2013
1	Histamine (Histamine Dihydrochloride)FDA Link 10/2012
1	Histamine Receptors (Histamine Receptor)IBA 10/2012
1	Metalloproteases (Metalloproteinases)IBA 07/2012
1	Orphan Nuclear ReceptorsIBA 07/2012
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 07/2012
1	Tumor Necrosis Factor InhibitorsIBA 03/2012
1	amsonic acid (DAS)IBA 01/2010
1	Rituximab (Mabthera)FDA Link 08/2009
1	Biomarkers (Surrogate Marker)IBA 08/2009
1	Rheumatoid FactorIBA 06/2007
1	Infliximab (Remicade)FDA Link 06/2007
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 01/2007
1	Methylprednisolone FDA LinkGeneric 11/2002

10	Therapeutics 03/2023 - 01/2007